Nitric oxide-scavenging nanogel suppresses onset of rheumatoid arthritis in vivo June 28, 2019 No Comments
Acer Therapeutics receives complete response letter from FDA for use of Edsivo June 26, 2019 No Comments
RSLV-132 moves into phase III for Sjogren syndrome after reduced fatigue seen in phase II June 25, 2019 No Comments
GSK initiates phase III trials of GSK-3196165 in moderate to severely active rheumatoid arthritis June 20, 2019 No Comments
Miransertib studied in patients with PIK3CA-related overgrowth spectrum and Proteus syndrome June 19, 2019 No Comments
RSS